Try our Advanced Search for more refined results
Searching dockets in Apotex Inc x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Patent - Abbreviated New Drug Application(ANDA) | New Jersey
Corporate Disclosure Statement (aty)
Corporate Disclosure Statement by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA U.S.A., INC. identifying Aurobindo Pharma Limited as Corporate Parent.. (GADEK, STANISLAW)
Text Order ~Util - Terminate Motions
TEXT ORDER: In light of the parties' agreement to transfer the related District of Delaware cases to this Court (see Mitsubishi Tanabe Pharma Corporation v. Cipla USA Inc., et al., 2:26-cv-7336-JCG-LDW), the motion to transfer this action to the District of Delaware (ECF 10) is hereby ADMINISTRATIVELY TERMINATED as moot. Motion terminated: 10 MOTION to Transfer Case to District of Delaware filed by APOTEX INC., APOTEX CORP. So Ordered by Magistrate Judge Leda D. Wettre on 8/19/26. (LM, )
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.